PHARMAX GROUP OÜ
Date of report 06.02.2025
Open the reports you want to print
Employees and salaries
PHARMAX GROUP OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
PHARMAX GROUP OÜ
Decision-makers?
Relations: 7
Turnover 2024: 12 717 238 €
Employees: 11
Maido Mölder
★★★★
......
Credit Score: Trustworthy
Reputation score: 10820
Date of birth: ......
Active relations 7
Relations: 9
Turnover 2024: 1 544 479 €
Employees: 4
Rasmus Kuklane
★★★★
......
Credit Score: Trustworthy
Reputation score: 4260
Date of birth: ......
Active relations 9
Relations: 5
Turnover 2024: 13 180 161 €
Employees: 11
Martin Henning
★★★★
......
Credit Score: Neutral
Reputation score: 10200
Date of birth: ......
Active relations 5
*Every member of the management board may represent the private limited company in concluding all transactions.
PHARMAX GROUP OÜ
History of right of representation?
Field
Trading
Business age
4y
Beneficial country:
Estonia
2020
2021
2022
2023
2024
2025
2020
2021
2022
2023
2024
2025
PHARMAX GROUP OÜ
Owners?
Former owners
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
PHARMAX GROUP OÜ
GoodwillPHARMAX GROUP OÜ
Taxes paid and estimated average salariesPHARMAX GROUP OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
PHARMAX GROUP OÜ
Sales revenue by business areaPHARMAX GROUP OÜ
Sales revenue by countryPHARMAX GROUP OÜ
Financial indicators and prognosisPHARMAX GROUP OÜ
Financial raiting: "VERY GOOD" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
PHARMAX GROUP OÜ
Annual reportsLiabilities and debts
PHARMAX GROUP OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
PHARMAX GROUP OÜ
Reports and assets-liabilities overview 06.02.2025?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
PHARMAX GROUP OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
PHARMAX GROUP OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | ...... € | ...... € | ...... € | ...... € | ...... |
PHARMAX GROUP OÜ
Bailiff's enforcement proceedings as of 06.02.2025?
Bailiff's enforcement proceedings MISSING
PHARMAX GROUP OÜ
Regulations of the Payment Order Department as of 06.02.2025?
Regulations of the Payment Order Department MISSING
PHARMAX GROUP OÜ
Court orders in the register as of 06.02.2025?
Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata
05.09.2024
Regulation number: Ä 50148772 / M2
Regulation status has entered into force: 05.09.2024
Date of enforcement of order or additional period: 05.09.2024
Regulation status: Jõustunud
Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata
16.07.2024
Regulation number: Ä 50148772 / M1
Regulation status has entered into force: 16.07.2024
Date of enforcement of order or additional period: 16.07.2024
Regulation status: Jõustunud
PHARMAX GROUP OÜ
Decisions of the Consumer Disputes Committee as of 06.02.2025?
Consumer disputes MISSING
PHARMAX GROUP OÜ
Court hearings as of 06.02.2025?
Court hearings MISSING
PHARMAX GROUP OÜ
Rulings as of 06.02.2025?
Court settlemets MISSING
PHARMAX GROUP OÜ
Notices and announcements as of 06.02.2025?
Announcements MISSING
Marketing
Business network
PHARMAX GROUP OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
PHARMAX GROUP OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.